These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 988965

  • 1. Cortical and striatal in vivo uptake and metabolism of plasma choline in the rat: effects of haloperidol and apomorphine.
    Aquilonius SM, Eckernäs SA.
    Acta Pharmacol Toxicol (Copenh); 1976 Jul; 39(1):129-40. PubMed ID: 988965
    [No Abstract] [Full Text] [Related]

  • 2. Differences in the action of various drugs on striatal acetylcholine and choline content in rats killed by decapitation of microwave radiation.
    Cheney DL, Racagni G, Zsilla G, Costa E.
    J Pharm Pharmacol; 1976 Jan; 28(1):75-7. PubMed ID: 6659
    [No Abstract] [Full Text] [Related]

  • 3. Effects of dopaminergic receptor agonists and antagonists on the activity of the neo-striatal cholinergic system.
    Guyenet PG, Javory AF, Beaujouan JC, Rossier BJ, Glowinski J.
    Brain Res; 1975 Feb 07; 84(2):227-44. PubMed ID: 234276
    [Abstract] [Full Text] [Related]

  • 4. Influence of noncholinergic drugs on rat striatal acetylcholine levels.
    McGeer PL, Grewaal DS, McGeer EG.
    Brain Res; 1974 Nov 15; 80(2):211-7. PubMed ID: 4154064
    [No Abstract] [Full Text] [Related]

  • 5. Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
    Tedford CE, Crosby G, Iorio LC, Chipkin RE.
    Eur J Pharmacol; 1992 Feb 11; 211(2):169-76. PubMed ID: 1535318
    [Abstract] [Full Text] [Related]

  • 6. Modulation of the endogenous acetylcholine release from rat striatal slices.
    Alberch J, Marsal J, Solsona C.
    Brain Res; 1985 Nov 04; 346(2):353-6. PubMed ID: 2996707
    [Abstract] [Full Text] [Related]

  • 7. Decrease in rat striatal acetylcholine levels by some direct- and indirect-acting dopaminergic antagonists.
    Consolo S, Ladinsky H, Bianchi S.
    Eur J Pharmacol; 1975 Nov 04; 33(2):345-51. PubMed ID: 1183479
    [Abstract] [Full Text] [Related]

  • 8. Cytidine(5')diphosphocholine enhances the ability of haloperidol to increase dopamine metabolites in the striatum of the rat and to diminish stereotyped behavior induced by apomorphine.
    Agut J, Coviella IL, Wurtman RJ.
    Neuropharmacology; 1984 Dec 04; 23(12A):1403-6. PubMed ID: 6543245
    [Abstract] [Full Text] [Related]

  • 9. Cholinergic-dopaminergic interaction in the striatum: the effect of 6-hydroxydopamine or pimozide treatment on the increased striatal acetylcholine levels induced by apomorphine, piribedil and d-amphetamine.
    Ladinsky H, Consolo S, Bianchi S, Samanin R, Ghezzi D.
    Brain Res; 1975 Feb 07; 84(2):221-6. PubMed ID: 1111831
    [Abstract] [Full Text] [Related]

  • 10. Effect of haloperidol and apomorphine treatment on dopamine receptors in pituitary and striatum.
    Friend WC, Brown GM, Jawahir G, Lee T, Seeman P.
    Am J Psychiatry; 1978 Jul 07; 135(7):839-41. PubMed ID: 665797
    [Abstract] [Full Text] [Related]

  • 11. Various dose-dependent influences of apomorphine on the acetylcholine turnover in striatum and mesolimbic areas of rat brain.
    Langnickel R, Bluth R, Oelssner W.
    Biomed Biochim Acta; 1983 Jul 07; 42(7-8):937-46. PubMed ID: 6651810
    [Abstract] [Full Text] [Related]

  • 12. Effects of haloperidol and apomorphine on the K+-depolarized overflow of [3H] dopamine from rat striatal slices.
    Miller JC, Friedhoff AJ.
    Biochem Pharmacol; 1979 Mar 01; 28(5):688-90. PubMed ID: 444255
    [No Abstract] [Full Text] [Related]

  • 13. In vivo inhibition of striatal acetycholine turnover by L-DOPA, apomophine and (plus)-amphetamine.
    Trabucchi M, Cheney DL, Racagni G, Costa E.
    Brain Res; 1975 Feb 21; 85(1):130-4. PubMed ID: 1109691
    [No Abstract] [Full Text] [Related]

  • 14. Increase in rat striatal acetylcholine content by bromocriptine: evidence for an indirect dopaminergic action.
    Consolo S, Ladinsky H, Pugnetti P, Fusi R, Crunelli V.
    Life Sci; 1981 Aug 03; 29(5):457-65. PubMed ID: 7278497
    [No Abstract] [Full Text] [Related]

  • 15. Dopamine receptor-coupled modulation of the K+-depolarized overflow of 3H-acetylcholine from rat striatal slices: alteration after chronic haloperidol and alpha-methyl-p-tyrosine pretreatment.
    Miller JC, Friedhoff AJ.
    Life Sci; 1979 Oct 01; 25(14):1249-55. PubMed ID: 513956
    [No Abstract] [Full Text] [Related]

  • 16. Developmental change in striatal concentration of homovanillic acid and 3,4-dihydroxyphenylacetic acid in response to apomorphine and haloperidol treatment.
    Nomura Y, Komori T, Okuda S, Segawa T.
    Arch Int Pharmacodyn Ther; 1979 Jan 01; 237(1):25-30. PubMed ID: 485682
    [Abstract] [Full Text] [Related]

  • 17. Enhancement of apomorphine-induced inhibition of striatal dopamine-turnover following chronic haloperidol.
    Gianutsos G, Hynes MD, Lal H.
    Biochem Pharmacol; 1975 Mar 01; 24(5):581-2. PubMed ID: 1125062
    [No Abstract] [Full Text] [Related]

  • 18. Effects of atropine treatment on cortical, striatal and hippocampal high-affinity uptake of choline in the mouse.
    Eckernäs SA, Sahlström L, Aquilonius SM.
    Life Sci; 1980 Aug 25; 27(8):641-5. PubMed ID: 7412492
    [No Abstract] [Full Text] [Related]

  • 19. Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase.
    Christiansen J, Squires RF.
    J Pharm Pharmacol; 1974 May 25; 26(5):367-9. PubMed ID: 4152779
    [No Abstract] [Full Text] [Related]

  • 20. Regulation of striatal acetylcholine concentration by dopamine receptors.
    Sethy VH, Van Woert MH.
    Nature; 1974 Oct 11; 251(5475):529-30. PubMed ID: 4421728
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.